Geographic and socioeconomic access disparities to ophthalmology clinical trials in Australia and the UK

BACKGROUND: Generalisability of clinical trial outcomes requires inclusion of a diverse study population. Factors that can limit this are geographic location and socioeconomic status. This study investigated the geographic and socio-demographic equity among participants in Australian and United Kingdom (UK)-based ophthalmology clinical trials. METHODS: We performed a registry-based analysis of ophthalmology clinical trials conducted between 2010 and 2021 and derived the geographic distribution and participant demographics from participating sites. RESULTS: 89.1% of recruitment centres in Australia were in metropolitan areas and only 0.8% were in rural areas. Trial participants recruited in New South Wales lived within a mean radius of 21 km of the clinical trial site. 1.4% of participants were recruited from non-metropolitan areas. We found socio-economic disparities among trial participants. 67.9% lived in the least deprived quintile and only 4.2% in most deprived areas. In contrast, UK participants (England and Northern Ireland) were more evenly distributed across with 11.3% from the most deprived and 23.5% from least deprived areas. Decentralised clinical trials (DCTs) in Australia suggested greater inclusion of participants from socioeconomically disadvantaged regions, with 11.1% recruited from the most deprived areas. More than half these participants were residing in rural Australia. CONCLUSIONS: Representation of trial participants in Australia is limited by the lack of inclusion of participants living in non-metropolitan and least affluent areas. Our results raise the hypothesis that DCTs may help to improve equity in trial participation, particularly in geographically vast countries like Australia, however, further research is needed to fully evaluate the potential benefits.

Authors

Institutions

Publication Details

Journal
Eye
Published
2026-11-17
DOI
https://doi.org/10.1038/s41433-026-04997-x
Primary Topic
Ethics in Clinical Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Geographic and socioeconomic access disparities to ophthalmology clinical trials in Australia and the UK

Nicole Ann Carnt, Mark C. Gillies, Gus Gazzard, David Paul Crabb et al.
4 links
Eye
Ethics in Clinical Research
article

Geographic and socioeconomic access disparities to ophthalmology clinical trials in Australia and the UK

Nicole Ann Carnt, Mark C. Gillies, Gus Gazzard, David Paul Crabb, Katharina Cornelia Bell, Peter McCluskey, Nicolas Winklmair, Jeremy C. K. Tan, Meg Jardine, Jonathan Guy Crowston
article en

Abstract

BACKGROUND: Generalisability of clinical trial outcomes requires inclusion of a diverse study population. Factors that can limit this are geographic location and socioeconomic status. This study investigated the geographic and socio-demographic equity among participants in Australian and United Kingdom (UK)-based ophthalmology clinical trials. METHODS: We performed a registry-based analysis of ophthalmology clinical trials conducted between 2010 and 2021 and derived the geographic distribution and participant demographics from participating sites. RESULTS: 89.1% of recruitment centres in Australia were in metropolitan areas and only 0.8% were in rural areas. Trial participants recruited in New South Wales lived within a mean radius of 21 km of the clinical trial site. 1.4% of participants were recruited from non-metropolitan areas. We found socio-economic disparities among trial participants. 67.9% lived in the least deprived quintile and only 4.2% in most deprived areas. In contrast, UK participants (England and Northern Ireland) were more evenly distributed across with 11.3% from the most deprived and 23.5% from least deprived areas. Decentralised clinical trials (DCTs) in Australia suggested greater inclusion of participants from socioeconomically disadvantaged regions, with 11.1% recruited from the most deprived areas. More than half these participants were residing in rural Australia. CONCLUSIONS: Representation of trial participants in Australia is limited by the lack of inclusion of participants living in non-metropolitan and least affluent areas. Our results raise the hypothesis that DCTs may help to improve equity in trial participation, particularly in geographically vast countries like Australia, however, further research is needed to fully evaluate the potential benefits.

Eye
National Health Service (GB), The University of Sydney (AU), City, University of London (GB), Concord Repatriation General Hospital (AU), UNSW Sydney (AU), National Institute for Health and Care Research (GB), Cooperative Trials Group for Neuro-Oncology (AU), Singapore Eye Research Institute (SG), Duke-NUS Medical School (SG), Moorfields Eye Hospital (GB), University College London (GB)
Snow Medical
Reduced inequalities, Good health and well-being
Ethics in Clinical Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon